IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 6, Pages 1766
Publisher
MDPI AG
Online
2018-06-14
DOI
10.3390/ijms19061766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
- (2017) Laura Kulik et al. HEPATOLOGY
- Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis
- (2017) Richard S. Finn et al. HEPATOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma
- (2017) Sven H. Loosen et al. JOURNAL OF HEPATOLOGY
- C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy
- (2017) Yuzhe Wei et al. JOURNAL OF SURGICAL RESEARCH
- Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
- (2017) Hyoung Woo Kim et al. MEDICINE
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
- (2017) Helen Ha et al. Theranostics
- Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data
- (2017) Susan Shamimi-Noori et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
- (2017) An Tang et al. Abdominal Radiology
- Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
- (2017) Shu-Yein Ho et al. PLoS One
- Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol
- (2016) Thomas J. Vogl et al. BMC CANCER
- Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis
- (2016) Y.W. Pan et al. GENETICS AND MOLECULAR RESEARCH
- IL-6 pathway in the liver: From physiopathology to therapy
- (2016) Dirk Schmidt-Arras et al. JOURNAL OF HEPATOLOGY
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1
- (2016) Huayang Wang et al. OncoImmunology
- IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
- (2015) Jung-Ta Kao et al. BMC GASTROENTEROLOGY
- Transarterial chemoembolization (TACE) for colorectal liver metastases—current status and critical review
- (2015) Alexander Massmann et al. LANGENBECKS ARCHIVES OF SURGERY
- Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model
- (2015) Beom Kyung Kim et al. LIVER INTERNATIONAL
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
- (2015) M Hatting et al. Cell Death & Disease
- Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism
- (2014) A. Jafarzadeh et al. TUMOR BIOLOGY
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
- (2013) Guobin He et al. CELL
- Targeting IL-8 in colorectal cancer
- (2012) Yan Ning et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
- (2011) Julien Edeline et al. CANCER
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search